NKX2-5 | NK2 homeobox 5 | Disease related genes Transcription factors
| | | | | Group enriched |
CA1 | Carbonic anhydrase I | Enzymes FDA approved drug targets Plasma proteins
| | | | | Group enriched |
HEMGN | Hemogen | | | | | | Group enriched |
LSP1 | Lymphocyte-specific protein 1; Uncharacterized protein | | | | | | Group enriched |
MLC1 | Megalencephalic leukoencephalopathy with subcortical cysts 1 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
LRTM1 | Leucine-rich repeats and transmembrane domains 1 | Predicted membrane proteins
| | | | | Group enriched |
SLC4A1 | Solute carrier family 4 (anion exchanger), member 1 (Diego blood group) | Blood group antigen proteins CD markers Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
TLX1 | T-cell leukemia homeobox 1 | Cancer-related genes Disease related genes Transcription factors
| | | | | Group enriched |
CASP16 | Caspase 16, apoptosis-related cysteine peptidase (putative) | Enzymes
| | | | | Group enriched |
LMAN1L | Lectin, mannose-binding, 1 like | Predicted membrane proteins
| | | | | Group enriched |
CHIT1 | Chitinase 1 (chitotriosidase) | Candidate cardiovascular disease genes Enzymes Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
CR2 | Complement component (3d/Epstein Barr virus) receptor 2 | CD markers Disease related genes Plasma proteins Predicted membrane proteins
| | | | | Group enriched |
FAM129C | Family with sequence similarity 129, member C | | | | | | Group enriched |
OTOA | Otoancorin | Disease related genes Predicted secreted proteins
| | | | | Group enriched |
PRRT4 | Proline-rich transmembrane protein 4 | Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
AC019206.1 | Uncharacterized protein | | | | | | Group enriched |
ADD2 | Adducin 2 (beta) | Cytoskeleton related proteins
| | | | | Group enriched |
AICDA | Activation-induced cytidine deaminase | Disease related genes Enzymes Potential drug targets
| | | | | Group enriched |
FCER2 | Fc fragment of IgE, low affinity II, receptor for (CD23) | Cancer-related genes CD markers Predicted membrane proteins
| | | | | Group enriched |
FCRL3 | Fc receptor-like 3 | CD markers Disease related genes Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
IGLL1 | Immunoglobulin lambda-like polypeptide 1 | CD markers Disease related genes Plasma proteins
| | | | | Group enriched |
MS4A1 | Membrane-spanning 4-domains, subfamily A, member 1 | CD markers Disease related genes FDA approved drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
CCL7 | Chemokine (C-C motif) ligand 7 | Cancer-related genes Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
CEACAM5 | Carcinoembryonic antigen-related cell adhesion molecule 5 | Cancer-related genes CD markers Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
CHRDL2 | Chordin-like 2 | Predicted secreted proteins
| | | | | Group enriched |
HAL | Histidine ammonia-lyase | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Group enriched |
SEC14L4 | SEC14-like 4 (S. cerevisiae) | | | | | | Group enriched |
CD19 | CD19 molecule | CD markers Disease related genes Predicted membrane proteins
| | | | | Group enriched |
CLEC17A | C-type lectin domain family 17, member A | Predicted membrane proteins
| | | | | Group enriched |
FCRLA | Fc receptor-like A | Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
P2RX5 | Purinergic receptor P2X, ligand-gated ion channel, 5 | Predicted membrane proteins
| | | | | Group enriched |
PHOSPHO1 | Phosphatase, orphan 1 | Enzymes
| | | | | Group enriched |
SLC22A16 | Solute carrier family 22 (organic cation/carnitine transporter), member 16 | Predicted membrane proteins
| | | | | Group enriched |
C12orf77 | Chromosome 12 open reading frame 77 | | | | | | Group enriched |
CLEC4M | C-type lectin domain family 4, member M | CD markers Predicted membrane proteins
| | | | | Group enriched |
DRD5 | Dopamine receptor D5 | Disease related genes FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Group enriched |
FCRL4 | Fc receptor-like 4 | Cancer-related genes CD markers Disease related genes Predicted membrane proteins
| | | | | Group enriched |
NME8 | NME/NM23 family member 8 | Disease related genes Predicted membrane proteins
| | | | | Group enriched |
TMCC2 | Transmembrane and coiled-coil domain family 2 | Predicted membrane proteins
| | | | | Group enriched |
ANKRD61 | Ankyrin repeat domain 61 | | | | | | Group enriched |
BLK | B lymphoid tyrosine kinase | Cancer-related genes Disease related genes Enzymes Potential drug targets
| | | | | Group enriched |
C19orf59 | Chromosome 19 open reading frame 59 | Predicted membrane proteins
| | | | | Group enriched |
CASP5 | Caspase 5, apoptosis-related cysteine peptidase | Cancer-related genes Enzymes Plasma proteins
| | | | | Group enriched |
CD72 | CD72 molecule | CD markers Predicted membrane proteins
| | | | | Group enriched |
CLEC4D | C-type lectin domain family 4, member D | Predicted membrane proteins
| | | | | Group enriched |
CNR2 | Cannabinoid receptor 2 (macrophage) | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Group enriched |
FCRL2 | Fc receptor-like 2 | CD markers Predicted membrane proteins
| | | | | Group enriched |
GDPD2 | Glycerophosphodiester phosphodiesterase domain containing 2 | Cytoskeleton related proteins Enzymes Predicted membrane proteins
| | | | | Group enriched |
HLA-DOB | Major histocompatibility complex, class II, DO beta | Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
MAB21L2 | Mab-21-like 2 (C. elegans) | | | | | | Group enriched |